CPMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CPMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Cannapharmarx's Average Total Inventories for the three months ended in Mar. 2025 was $0.97 Mil. Cannapharmarx's Cost of Goods Sold for the three months ended in Mar. 2025 was $0.84 Mil. Hence, Cannapharmarx's Days Inventory for the three months ended in Mar. 2025 was 106.00.
The historical rank and industry rank for Cannapharmarx's Days Inventory or its related term are showing as below:
During the past 13 years, Cannapharmarx's highest Days Inventory was 106.34. The lowest was 103.52. And the median was 103.52.
Cannapharmarx's Days Inventory declined from Mar. 2024 (205.36) to Mar. 2025 (106.00).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year. Cannapharmarx's Inventory Turnover for the three months ended in Mar. 2025 was 0.86.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cannapharmarx's Inventory-to-Revenue for the three months ended in Mar. 2025 was 2.91.
The historical data trend for Cannapharmarx's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannapharmarx Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Days Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | 103.52 |
Cannapharmarx Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
Days Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
205.36 | - | 168.16 | 46.53 | 106.00 |
For the Drug Manufacturers - Specialty & Generic subindustry, Cannapharmarx's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Cannapharmarx's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cannapharmarx's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cannapharmarx's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as
Days Inventory (A: Dec. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2023 ) | + | Total Inventories (A: Dec. 2024 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2024 ) | * | Days in Period |
= | ( (1.134 | + | 0.996) | / | 2 ) | / | 3.755 | * | 365 |
= | 1.065 | / | 3.755 | * | 365 | ||||
= | 103.52 |
Cannapharmarx's Days Inventory for the quarter that ended in Mar. 2025 is calculated as:
Days Inventory (Q: Mar. 2025 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Dec. 2024 ) | + | Total Inventories (Q: Mar. 2025 )) | / | count ) | / | Cost of Goods Sold (Q: Mar. 2025 ) | * | Days in Period |
= | ( (0.996 | + | 0.951) | / | 2 ) | / | 0.838 | * | 365 / 4 |
= | 0.9735 | / | 0.838 | * | 365 / 4 | ||||
= | 106.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannapharmarx (OTCPK:CPMD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cannapharmarx's Inventory Turnover for the three months ended in Mar. 2025 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0.838 | / | 0.9735 | |
= | 0.86 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cannapharmarx's Inventory to Revenue for the three months ended in Mar. 2025 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0.9735 | / | 0.335 | |
= | 2.91 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Cannapharmarx's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Anthony Michael Panek | director | 95 SOUTH STATE STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Dominic Colvin | director, officer: Chief Executive Officer | C/O CANNAPHARMARX, INC., 2 PARK PLAZA, SUITE 1200-B, IRVINE CA 92614 |
John Hamilton Cassels | officer: Chief Financial Officer | SUITE 500, 209 8TH AVENUE SW, CALGARY A0 T2P 1B8 |
Richard Dale Orman | director | 302, 3204 RIDEAU PLACE SW, CALGARY A0 T2S1Z2 |
Andrew Clifford Steedman | officer: Chief Operating Officer | 1131 RIVERDALE AVE SW, CALGARY A0 T2S 0Y9 |
Marc R Branson | director | 977 KEITH ROAD, WEST VANCOUVER A1 V7T 1M6 |
Gary J Herick | 10 percent owner | 7609 RALSTON ROAD, ARVADA CO 80002 |
James F Samuelson | director | PO BOX 22, NEWPORT BEACH CA 92662 |
Matthew Nicosia | director, 10 percent owner | 2 PARK PLAZA, SUITE 400, IRVINE CA 92614 |
Robert M Liess | director | 2602 W. SAM ALLEN RD., PLANT CITY FL 33565 |
Mathew D Sherwood | director | P.O. BOX 4375, DILLON CO 80435 |
James E Smeeding | director | 4029 GILBERT AVENUE, DALLAS TX 75219 |
Elie M Khalife | director | 9447 E. CROSS CREEK STREET, WICHITA KS 67206 |
Steven J Rule | director | C/O CANNAPHARMARX, INC., ONE COLLINS DRIVE, SUITE 100, CARNEYS POINT NJ 08069 |
Alexander R Giaquinto | director | 120 MOUNTAIN VIEW BOULEVARD, BASKING RIDGE NJ 07920 |
From GuruFocus
By ACCESSWIRE • 03-14-2024
By ACCESSWIRE • 02-16-2024
By ACCESSWIRE • 04-02-2024
By ACCESSWIRE • 05-20-2024
By ACCESSWIRE • 02-23-2024
By ACCESSWIRE ACCESSWIRE • 01-30-2023
By GuruFocus News • 05-06-2025
By ACCESSWIRE ACCESSWIRE • 06-29-2022
By ACCESSWIRE • 02-15-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.